Cargando…
Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma
[Image: see text] Anticoagulation therapy is a mainstay of the treatment of thrombotic disorders; however, conventional anticoagulants trade antithrombotic benefits for bleeding risk. Factor (f) XI deficiency, known as hemophilia C, rarely causes spontaneous bleeding, suggesting that fXI plays a lim...
Autores principales: | Modrzycka, Sylwia, Kołt, Sonia, Adams, Ty E., Potoczek, Stanisław, Huntington, James A., Kasperkiewicz, Paulina, Drąg, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041521/ https://www.ncbi.nlm.nih.gov/pubmed/36898159 http://dx.doi.org/10.1021/acs.jmedchem.2c00845 |
Ejemplares similares
-
Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma
por: Modrzycka, Sylwia, et al.
Publicado: (2022) -
Detection of Active
Granzyme A in NK92 Cells with
Fluorescent Activity-Based Probe
por: Kołt, Sonia, et al.
Publicado: (2020) -
Determination of extended substrate specificity of the MALT1 as a strategy for the design of potent substrates and activity-based probes
por: Kasperkiewicz, Paulina, et al.
Publicado: (2018) -
Green-Emitting
4,5-Diaminonaphthalimides in Activity-Based
Probes for the Detection of Thrombin
por: Krzeszewski, Maciej, et al.
Publicado: (2022) -
Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes
por: Poreba, Marcin, et al.
Publicado: (2018)